Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis

被引：0
|
作者：
Cooper, C
Reginster, JY
McClung, M
Zorich, NL
Li, Z
机构：
[1] Univ Southampton, Southampton, Hants, England
[2] Univ Liege, Liege, Belgium
[3] Oregon Osteoporosis Ctr, Portland, OR USA
[4] Procter & Gamble Pharmaceut, Mason, OH USA
来源：
BONE | 2001年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 50 条
  • [31] HIP FRACTURE, SKELETAL FRAGILITY, OSTEOPOROSIS AND HORMONAL DEPRIVATION IN ELDERLY WOMEN
    SPECHT, EE
    WESTERN JOURNAL OF MEDICINE, 1980, 133 (04): : 297 - 303
  • [32] Oral Bisphosphonates and Hip Fracture Risk in Elderly Women
    Erviti, Juan
    Timoner, Julia
    Alonso, Alvaro
    Gorricho, Javier
    Lopez, Antonio
    Huerta, Consuelo
    Oliva, Belen
    Gil, Miguel
    De Abajo, Francisco
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S28 - S29
  • [33] Risedronate rapidly and consistently reduces vertebral fracture risk in elderly postmenopausal women
    Roux, C
    Wasnich, R
    Adachi, J
    Zippel, H
    Bos, K
    Fogelman, I
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S197 - S198
  • [34] OSTEOPOROSIS AND THE RISK OF HIP FRACTURE
    MELTON, LJ
    WAHNER, HW
    RICHELSON, LS
    OFALLON, WM
    RIGGS, BL
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 124 (02) : 254 - 261
  • [35] Clinical risk factors for prediction of hip osteoporosis in elderly women
    Kayan, K
    Bal, S
    Kohler, B
    Jalava, T
    Ball, A
    Cliff, J
    Charlesworth, D
    Bostock, J
    Kanis, JA
    McCloskey, EV
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S8 - S8
  • [36] Risk factors for hip fracture in Japanese elderly women with osteoporosis: Applicability of biochemical markers in bone turnover
    Shiga, Toshiki
    Tsuji, Yoshiro
    Fujioka, Mikihiro
    Kubo, Toshikazu
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2009, 9 (01) : 69 - 74
  • [37] RETRACTED: Risedronate therapy for prevention of hip fracture after stroke in elderly women (Retracted Article)
    Poole, KES
    Warburton, EA
    Reeve, J
    NEUROLOGY, 2005, 65 (09) : 1513 - 1513
  • [38] Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial
    Black, DM
    Thompson, DE
    Bauer, DC
    Ensrud, K
    Musliner, T
    Hochberg, MC
    Nevitt, MC
    Suryawanshi, S
    Cummings, SR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11): : 4118 - 4124
  • [39] Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data
    Adachi, JD
    Rizzoli, R
    Boonen, S
    Li, ZQ
    Meredith, MP
    Chesnut, CH
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 17 (02) : 150 - 156
  • [40] Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: A meta-analysis of individual patient data
    Adachi J.D.
    Rizzoli R.
    Boonen S.
    Li Z.
    Meredith M.P.
    Chesnut III C.H.
    Aging Clinical and Experimental Research, 2005, 17 (2) : 150 - 156
12345